NutriSelect.ai is pleased to announce that RCS, Inc., a global Contract Research Organization (CRO), has formally joined the NutriSelect CRO Consortium following the execution of a strategic Letter of Intent and mutual NDA.
RCS is a CDSCO-registered CRO with a global footprint, supporting pharmaceutical, nutraceutical, biopharmaceutical, and medical device companies across the full clinical development lifecycle—from preclinical research through Phase I–IV trials. Their comprehensive infrastructure and regulatory expertise make them a strong addition to NutriSelect’s growing ecosystem of science-first research partners.
This collaboration aligns with NutriSelect’s mission to elevate evidence-based supplementation and healthspan innovation through Precision Supplement Intelligence™ and its proprietary NScore™ rating system. Through the consortium, NutriSelect works with leading CROs to help product brands and ingredient suppliers generate high-quality clinical evidence, while also using aggregated, anonymized insights to inform future research priorities aligned with real-world consumer needs.
RCS capabilities include:
As part of the consortium framework, NutriSelect may refer product brands seeking clinical validation to RCS, while RCS may introduce NutriSelect to sponsors looking to enhance product differentiation, transparency, and post-study credibility through AI-powered evidence evaluation.
“RCS brings global scale, regulatory depth, and an end-to-end clinical mindset that fits well with how we’re building the NutriSelect ecosystem,” said Dr. Bill Clark, PhD, Founder & CEO of NutriSelect.ai. “This partnership strengthens our ability to connect credible science with real-world impact for brands, practitioners, and consumers alike.”
Dr. Rohit Singh, Co-Founder, President, MD & CEO of RCS, added:
“At RCS, our mission has always been to bring rigorous, globally credible science to innovators who are serious about making a real impact on human health. NutriSelect’s approach—combining clinical evidence, transparency, and AI-driven intelligence—aligns strongly with how we believe the future of nutraceutical and healthspan research should evolve. We’re excited to join the NutriSelect CRO Consortium and collaborate on advancing evidence-based supplementation worldwide.”
With the addition of RCS, NutriSelect’s CRO Consortium continues to grow alongside established partners including Radicle Science, The Center for Applied Health Sciences, Alethios, and Reputable Health, reinforcing a shared mission to elevate scientific integrity, transparency, and trust in the global supplement and healthspan ecosystem.
Learn more about RCS at www.rclinicalsolution.com
